{
    "N/R/U": null,
    "Applicant": "Bioverativ Therapeutics, Inc.",
    "BLA Number": "125771",
    "Proprietary Name": "ALTUVIIIO",
    "Proper Name": "antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl",
    "BLA Type": "351(a)",
    "Strength": "2000IU",
    "Dosage Form": "For Injection",
    "Route of Administration": "Intravenous",
    "Product Presentation": "Single-Dose Vial",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "February 22, 2023",
    "Ref. Product Proper Name": null,
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "0",
    "Submission Type": "Original",
    "License Number": "2078",
    "Product Number": "005",
    "Center": "CBER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": "February 22, 2030",
    "drug": [
        {
            "name": "antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl"
        }
    ]
}